Early warning signals in psychopathology: what do they tell?

Complex systems Early warning signals Momentary affective states Psychopathology Symptom development

Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
14 10 2020
Historique:
received: 07 11 2019
accepted: 10 08 2020
entrez: 14 10 2020
pubmed: 15 10 2020
medline: 12 2 2021
Statut: epublish

Résumé

Despite the increasing understanding of factors that might underlie psychiatric disorders, prospectively detecting shifts from a healthy towards a symptomatic state has remained unattainable. A complex systems perspective on psychopathology implies that such symptom shifts may be foreseen by generic indicators of instability, or early warning signals (EWS). EWS include, for instance, increasing variability, covariance, and autocorrelation in momentary affective states-of which the latter was studied. The present study investigated if EWS predict (i) future worsening of symptoms as well as (ii) the type of symptoms that will develop, meaning that the association between EWS and future symptom shifts would be most pronounced for congruent affective states and psychopathological domains (e.g., feeling down and depression). A registered general population cohort of adolescents (mean age 18 years, 36% male) provided ten daily ratings of their affective states for 6 consecutive days. The resulting time series were used to compute EWS in feeling down, listless, anxious, not relaxed, insecure, suspicious, and unwell. At baseline and 1-year follow-up, symptom severity was assessed by the Symptom Checklist-90 (SCL-90). We selected four subsamples of participants who reported an increase in one of the following SCL-90 domains: depression (N = 180), anxiety (N = 192), interpersonal sensitivity (N = 184), or somatic complaints (N = 166). Multilevel models showed that EWS in feeling suspicious anticipated increases in interpersonal sensitivity, as hypothesized. EWS were absent for other domains. While the association between EWS and symptom increases was restricted to the interpersonal sensitivity domain, post hoc analyses showed that symptom severity at baseline was related to heightened autocorrelations in congruent affective states for interpersonal sensitivity, depression, and anxiety. This pattern replicated in a second, independent dataset. The presence of EWS prior to symptom shifts may depend on the dynamics of the psychopathological domain under consideration: for depression, EWS may manifest only several weeks prior to a shift, while for interpersonal sensitivity, EWS may already occur 1 year in advance. Intensive longitudinal designs where EWS and symptoms are assessed in real-time are required in order to determine at what timescale and for what type of domain EWS are most informative of future psychopathology.

Sections du résumé

BACKGROUND
Despite the increasing understanding of factors that might underlie psychiatric disorders, prospectively detecting shifts from a healthy towards a symptomatic state has remained unattainable. A complex systems perspective on psychopathology implies that such symptom shifts may be foreseen by generic indicators of instability, or early warning signals (EWS). EWS include, for instance, increasing variability, covariance, and autocorrelation in momentary affective states-of which the latter was studied. The present study investigated if EWS predict (i) future worsening of symptoms as well as (ii) the type of symptoms that will develop, meaning that the association between EWS and future symptom shifts would be most pronounced for congruent affective states and psychopathological domains (e.g., feeling down and depression).
METHODS
A registered general population cohort of adolescents (mean age 18 years, 36% male) provided ten daily ratings of their affective states for 6 consecutive days. The resulting time series were used to compute EWS in feeling down, listless, anxious, not relaxed, insecure, suspicious, and unwell. At baseline and 1-year follow-up, symptom severity was assessed by the Symptom Checklist-90 (SCL-90). We selected four subsamples of participants who reported an increase in one of the following SCL-90 domains: depression (N = 180), anxiety (N = 192), interpersonal sensitivity (N = 184), or somatic complaints (N = 166).
RESULTS
Multilevel models showed that EWS in feeling suspicious anticipated increases in interpersonal sensitivity, as hypothesized. EWS were absent for other domains. While the association between EWS and symptom increases was restricted to the interpersonal sensitivity domain, post hoc analyses showed that symptom severity at baseline was related to heightened autocorrelations in congruent affective states for interpersonal sensitivity, depression, and anxiety. This pattern replicated in a second, independent dataset.
CONCLUSIONS
The presence of EWS prior to symptom shifts may depend on the dynamics of the psychopathological domain under consideration: for depression, EWS may manifest only several weeks prior to a shift, while for interpersonal sensitivity, EWS may already occur 1 year in advance. Intensive longitudinal designs where EWS and symptoms are assessed in real-time are required in order to determine at what timescale and for what type of domain EWS are most informative of future psychopathology.

Identifiants

pubmed: 33050891
doi: 10.1186/s12916-020-01742-3
pii: 10.1186/s12916-020-01742-3
pmc: PMC7557008
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

269

Subventions

Organisme : European Research Council
ID : 681466
Pays : International

Références

Emotion. 2018 Mar;18(2):229-236
pubmed: 28569537
Psychol Bull. 2015 Jul;141(4):901-30
pubmed: 25822133
Nonlinear Dynamics Psychol Life Sci. 2012 Jul;16(3):353-79
pubmed: 22695153
Clin Psychol Rev. 2007 Jul;27(6):715-23
pubmed: 17316941
J Abnorm Psychol. 2012 Nov;121(4):819-29
pubmed: 22708886
Sci Rep. 2015 Dec 09;5:17501
pubmed: 26647650
Science. 2012 Oct 19;338(6105):344-8
pubmed: 23087241
J Affect Disord. 2020 Jan 15;261:67-75
pubmed: 31600589
Cogn Emot. 2012;26(8):1412-27
pubmed: 22671768
Twin Res Hum Genet. 2019 Dec;22(6):454-459
pubmed: 31496455
Twin Res. 1998 Dec;1(4):167-75
pubmed: 10100808
World J Biol Psychiatry. 2009;10(4 Pt 2):658-68
pubmed: 18792858
Psychother Psychosom. 2016;85(2):114-6
pubmed: 26821231
Front Psychol. 2016 Jun 14;7:891
pubmed: 27378986
Front Psychol. 2016 Jan 08;6:1997
pubmed: 26779099
Cogn Emot. 2015;29(3):527-38
pubmed: 24820350
Emot Rev. 2015 Oct;7(4):355-361
pubmed: 27617032
BMC Med. 2020 Apr 8;18(1):99
pubmed: 32264914
Psychother Psychosom. 1999;68(4):199-206
pubmed: 10396011
JAMA Psychiatry. 2017 May 1;74(5):528-534
pubmed: 28355471
Nature. 2009 Sep 3;461(7260):53-9
pubmed: 19727193
Emotion. 2020 Mar;20(2):179-191
pubmed: 30589297
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
Ecology. 2012 Feb;93(2):264-71
pubmed: 22624308
Nonlinear Dynamics Psychol Life Sci. 2014 Apr;18(2):155-76
pubmed: 24560009
Schizophr Bull. 2011 Mar;37(2):244-7
pubmed: 21224492
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):87-92
pubmed: 24324144
Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):E879
pubmed: 24757714
Front Psychol. 2014 Oct 02;5:1089
pubmed: 25324801
Biol Cybern. 2010 Mar;102(3):197-207
pubmed: 20084517
Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):E878
pubmed: 24550518
J Affect Disord. 2019 Apr 15;249:270-277
pubmed: 30784724
Emotion. 2012 Apr;12(2):283-9
pubmed: 21988744
J Pers Soc Psychol. 2002 Jan;82(1):128-47
pubmed: 11811630
Annu Rev Sociol. 2014 Jul;40:31-53
pubmed: 30111904
Nat Hum Behav. 2019 May;3(5):478-491
pubmed: 30988484
Emotion. 2015 Oct;15(5):625-36
pubmed: 25844974
Perspect Psychol Sci. 2011 Nov;6(6):589-609
pubmed: 26168379
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Psychol Med. 2019 Feb;49(3):380-387
pubmed: 30131079
Psychol Sci. 2010 Jul;21(7):984-91
pubmed: 20501521
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6106-E6115
pubmed: 29915059

Auteurs

Marieke J Schreuder (MJ)

Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), University of Groningen, University Medical Center Groningen, Internal Postal Code: CC72, Triade Building Entrance 24, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. m.j.schreuder@umcg.nl.

Catharina A Hartman (CA)

Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), University of Groningen, University Medical Center Groningen, Internal Postal Code: CC72, Triade Building Entrance 24, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

Sandip V George (SV)

Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), University of Groningen, University Medical Center Groningen, Internal Postal Code: CC72, Triade Building Entrance 24, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

Claudia Menne-Lothmann (C)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University, Universiteitssingel 40, 6299 ER, Maastricht, The Netherlands.

Jeroen Decoster (J)

University Psychiatric Centre, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Department of Neurosciences, Center for Public Health Psychiatry, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Ruud van Winkel (R)

University Psychiatric Centre, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Department of Neurosciences, Center for Clinical Psychiatry, KU Leuven, Kapucijnenvoer 7, 3000, Leuven, Belgium.

Philippe Delespaul (P)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University, Universiteitssingel 40, 6299 ER, Maastricht, The Netherlands.
Mondriaan Mental Health Care, John F. Kennedylaan 301, 6419 XZ, Heerlen, The Netherlands.

Marc De Hert (M)

University Psychiatric Centre, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Department of Neurosciences, Center for Clinical Psychiatry, KU Leuven, Kapucijnenvoer 7, 3000, Leuven, Belgium.
Antwerp Health Law and Ethics Chair - AHLEC, University of Antwerp, Antwerp, Belgium.

Catherine Derom (C)

Centre of Human Genetics, University Hospital Leuven, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Department of Obstetrics and Gynecology, Ghent University Hospital, Ghent University, C. Heymanslaan 10, 9000, Ghent, Belgium.

Evert Thiery (E)

Department of Neurology, Ghent University Hospital, Ghent University, C. Heymanslaan 10, 9000, Ghent, Belgium.

Bart P F Rutten (BPF)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University, Universiteitssingel 40, 6299 ER, Maastricht, The Netherlands.

Nele Jacobs (N)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University, Universiteitssingel 40, 6299 ER, Maastricht, The Netherlands.
Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Valkenburgerweg 177, 6419 AT, Heerlen, The Netherlands.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University, Universiteitssingel 40, 6299 ER, Maastricht, The Netherlands.
Department of Psychosis Studies, Institute of Psychiatry, King's Health Partners, King's College London, De Crespigny Park, London, SE5 8AF, UK.
Department Psychiatry, Brain Center Rudolf Magnus,, Utrecht University Medical Centre, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.

Johanna T W Wigman (JTW)

Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), University of Groningen, University Medical Center Groningen, Internal Postal Code: CC72, Triade Building Entrance 24, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

Marieke Wichers (M)

Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), University of Groningen, University Medical Center Groningen, Internal Postal Code: CC72, Triade Building Entrance 24, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH